2m 2m 2m 2m 2m 2m 2m
NOVAVAX (NVAX)
NASDAQ
$9.09+$0.09 (+1.00%)
Price as of Jun 23, 2026 4:46 PM EDT- $1.5BMarket Cap
- 42.63%1-Year Change
- BiotechnologyIndustry
NOVAVAX (NVAX)
$9.09+$0.09 (+1.00%)
Earnings Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -1 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -7.39% | ||
12-Month Momentum | 44.62% | ||
3-Month Risk Adjusted Momentum | -28.25% | ||
12-Month Risk Adjusted Momentum | 69.32% |
True Yield
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -3.73% |
Financial Health Score
Valuation | NVAX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |